Антирак груди. Джейн ПлантЧитать онлайн книгу.
and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/75/0000077539.html
87
Miller, M. A., Hildebrand, J. R., White, T. C., Hammond, E. G., Madson, K. S., and Collier, R. J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science, 72, Supplement 1, 186–187.
88
Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393–1396.
89
Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science, 279, January.
90
Pollack, M. N., Huynh, H. T. and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100.
91
Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563–566.
92
Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk: A Prospective Study. Science, 279, January.
93
Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373–1375.
94
Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services, 26, 1, 173–185.
95
Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453–461.
96
Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week, Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17th Street, N. W., Suite 413, Washington DC 20006.
97
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.mt/comm/dg24/health/sc/scv/out19_en.html
98
D'Ercole, J. A., Underwood, L. E. and Van Wyk, J. J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth. J. Pediatr., 90, 3, 375–381. See also Cullen, K. J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, vol. 50, pp. 48–53.
99
De Leon, D. D., Wilson, D. M., Powers, M. and Rosenfeld, R. G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors, 6, 327–336.
100
Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492–497.
101
Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492–497.
102
Musgrove, E. A. and Sutherland, R. I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur. J. Cancer, 29A, 16, 2273–2279.
103
Heldrin, C. N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell, 37:9, 20.
104
Macaulay, V. M., 1992. Insulin-like growth factors and cancer. Br. J. Cancer, 65, 311–320.
105
Underwood, L. E., D'Ercole, J. A. and Van Wyk, J. J., 1980. Somatomedin-C and the assessment of growth. Ped. Clin. N. Amer., 27, 4, 771–782, and Perdue, J. F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J. Biochem Cell Bio., 62, 1237–1245.
106
Outwater, J. L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.
107
The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html
108
Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.
109
Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.
110
Challacombe. D. N. and Wheeler, E. E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet, 344, 17 September, p. 815.
111
Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Research, Jan 15, 55(2), 303–306.
112
Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science, 74, 167–201.
113
Xian, C., 1995. Degradation of IGF- 1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein. Journal of Endocrinology, 146, 2, 1 August, p. 215, and Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.
114
Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453–461.
115
Harasuchi, S., Good, R. A., Engelman, R. W. and Day, N. K., 1992. Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J. Cancer, 52, 923–933.
116
Clevenger, C, V., Chang, W. F., Ngo, W., Pasha, T. L., Montone, K. T. And Tomaszewski, J. E., 1995. Expression of prolactin and